Aytu Biopharma

AYTUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$23.935 M

$2.23 +4.94%

Close of 22 Sept 2026

Revenue

$66.4M

#2644 by revenue

Earnings

-$13.6M

Loss-making

Shares outstanding

10,733,208

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#384GridAI TechnologiesGRDX$27.7M
#385TherapeuticsMDTXMD$25.0M
#386Aytu BiopharmaAYTU$23.9M
#387Radiopharm TheranosticsRADX$23.9M
#388NextCureNXTC$23.7M

What if Aytu Biopharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,816,862

Per share 1,263,167× higher

Bitcoin $1.74T

$162,267.89

Per share 72,766× higher

Nvidia $5.52T

$513,897.33

Per share 230,447× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Aytu Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.